CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy

Overview of attention for article published in Frontiers in immunology, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 38,040 followers.

RT @FrontImmunol: New Research: CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools fo…

RT @FrontImmunol: New Research: CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools fo…

RT @FrontImmunol: New Research: CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools fo…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.